UK markets close in 4 hours 8 minutes

Nano-X Imaging Ltd. (NNOX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
11.47+0.04 (+0.35%)
At close: 04:00PM EDT
11.55 +0.08 (+0.70%)
Pre-market: 07:22AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close11.43
Open11.47
Bid0.00 x 1100
Ask0.00 x 1300
Day's range11.45 - 12.47
52-week range8.23 - 28.60
Volume695,855
Avg. volume428,688
Market cap598.903M
Beta (5Y monthly)1.72
PE ratio (TTM)N/A
EPS (TTM)-1.43
Earnings date15 Nov 2022 - 21 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est36.75
  • Motley Fool

    Here's Why Nanox Stock Soared on Wednesday

    Shares of Nano-X Imaging (NASDAQ: NNOX), commonly called Nanox, soared on Wednesday after it revealed it's taken the next step toward commercializing its flagship medical device. As of 12:20 p.m. ET, Nanox stock was up 21%. Nanox had its initial public offering (IPO) in 2020, promising to disrupt the X-ray industry with its digital-3D imaging machines that will be cheaper for doctors to use.

  • Motley Fool

    3 Stocks to Buy and Hold for the Long Term

    One of the big advantages individual investors have over fund managers is that no one is looking over their shoulders for quick results. In this roundtable, three Motley Fool contributors picked healthcare stocks that they believe will be big winners for a long time. Here's why they recommend OrthoPediatrics (NASDAQ: KIDS), Compass Pathways (NASDAQ: CMPS), and Nano-X Imaging (NASDAQ: NNOX).

  • Motley Fool

    Nano-X Imaging Ltd. (NNOX) Q2 2022 Earnings Call Transcript

    Earlier today, Nano-X Imaging Limited released its financial results for the quarter ended June 30, 2022. Erez Meltzer, chief executive officer; and Ran Daniel, chief financial officer, will host this morning's call. Before we get started, I would like to remind everyone that management will be making statements during this call that include forward-looking statements regarding the company's financial results, research and development, manufacturing and commercialization activities, regulatory process operations, and other matters.